<SEC-DOCUMENT>0001628280-25-048525.txt : 20251104
<SEC-HEADER>0001628280-25-048525.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104070358
ACCESSION NUMBER:		0001628280-25-048525
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251104
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MADRIGAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001157601
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33277
		FILM NUMBER:		251446396

	BUSINESS ADDRESS:	
		STREET 1:		200 BARR HARBOR DRIVE, SUITE 400
		CITY:			WEST CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
		BUSINESS PHONE:		404-380-9263

	MAIL ADDRESS:	
		STREET 1:		200 BARR HARBOR DRIVE, SUITE 400
		CITY:			WEST CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNTA PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20010815
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mdgl-20251104.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cbd92466-6b99-4701-9438-a726300e9607,g:ce9ea39c-4a4a-46a4-9263-4308ab4f25b2,d:fac48aa49eda47809986dfe6b6bb937a-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdgl-20251104</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001157601</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-23">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdgl-20251104.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001157601</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-04</xbrli:startDate><xbrli:endDate>2025-11-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifac48aa49eda47809986dfe6b6bb937a_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:115%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 4, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">____________________</span></div><div style="margin-top:16pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">MADRIGAL PHARMACEUTICALS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">____________________</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33277</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">04-3508648</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">Four Tower Bridge<br/>200 Barr Harbor Drive,</ix:nonNumeric>  <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">West Conshohocken,</ix:nonNumeric>  <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Pennsylvania</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">19428</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">267</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">824-2827</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Registrant&#8217;s telephone number, including area code</span></div><div style="margin-top:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">____________________</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.0001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">MDGL</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:115%">o</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ifac48aa49eda47809986dfe6b6bb937a_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item&#8201;2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On November 4, 2025, Madrigal Pharmaceuticals, Inc. (the &#8220;Company&#8221;) issued a press release announcing the Company&#8217;s financial results for the fiscal quarter ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Current Report on Form 8-K and the accompanying Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.</span></div><div><span><br/></span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item&#8201;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(d) Exhibits</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a3q25pressrelease.htm">Press Release Dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a3q25pressrelease.htm">November</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a3q25pressrelease.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a3q25pressrelease.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a3q25pressrelease.htm">, 2025</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr></table></div><div id="ifac48aa49eda47809986dfe6b6bb937a_10"></div><div style="margin-top:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="ifac48aa49eda47809986dfe6b6bb937a_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.750%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:114%">MADRIGAL PHARMACEUTICALS, INC.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Mardi Dier</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Name: Mardi Dier</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Title: Executive Vice President and Chief Financial Officer </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:114%">Date: November 4, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a3q25pressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i619930702c874384b3746ec2bf558a50_37"></div><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Madrigal Pharmaceuticals </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Reports</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Third</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">-Quarter </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> Financial Results and </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Provides Corporate Updates</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">Third-quarter 2025 Rezdiffra&#8482; (resmetirom) net sales of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">$287.3 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">As of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">September 30, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">, more than 29,500 patients on Rezdiffra </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">Closed global licensing agreement with CSPC Pharma to add oral GLP-1 to pipeline</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">   </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">New Orange Book listed patent for Rezdiffra providing protection into 2045 </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">Launched Rezdiffra in Germany following European Commission approval </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">Reports cash, cash equivalents, restricted cash and marketable securities of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">$1.1 billion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">  as of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Sept. 30, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.03pt">Company to host conference call today, Nov. 4, 2025, at 8 a.m. EST</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">CONSHOHOCKEN, Pa.,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Nov. 4, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> &#8211; Madrigal Pharmaceuticals, Inc. (NASDAQ&#58; MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today reports </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">third</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">-quarter </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> financial results and provides corporate updates.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Bill Sibold, Chief Executive Officer of Madrigal, stated&#58; &#8220;Six quarters into Rezdiffra&#8217;s launch, we continue to execute on all fronts. Most gratifying is the impact we&#8217;re having, with more than 29,500 patients on therapy and more than 10,000 healthcare providers prescribing Rezdiffra. With quarterly sales now annualizing above $1 billion, Rezdiffra is quickly becoming one of the most successful specialty launches in the industry and we&#8217;re still early, with greater than 90 percent of our target population yet to be treated. As we look ahead to 2026, Rezdiffra is poised for growth and continued broad, first-line access for patients.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Sibold continued&#58; &#8220;We&#8217;re advancing a focused strategy to extend our leadership by building a pipeline of complementary therapies. We recently added an oral GLP-1 that we intend to develop in combination with Rezdiffra to drive greater efficacy while maintaining strong tolerability. Like other large therapeutic areas, we believe MASH will require multiple mechanisms and tailored treatment regimens &#8211; and we&#8217;re well-positioned to lead that evolution. Alongside this, our pivotal Phase 3 Rezdiffra trial in F4c</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">continues to advance and could make Rezdiffra the first approved treatment in compensated MASH cirrhosis.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> With U.S. patent protection for Rezdiffra into 2045, we can thoughtfully invest, innovate and lead the fight against MASH for years to come.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Third-Quarter </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> and Recent Corporate Updates </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Closed transaction to license global rights to oral GLP-1 (MGL-2086) to combine with Rezdiffra</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.4pt">Madrigal completed the licensing agreement with CSPC Pharma for an oral glucagon-like peptide-1 (GLP-1) receptor agonist and orforglipron derivative. The global license agreement supports Madrigal&#8217;s strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy, Rezdiffra. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.4pt">MGL-2086 (formerly SYH2086) is expected to enter the clinic in the first half of 2026. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">New Orange Book listed Rezdiffra patent provides protection into 2045</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.4pt">A new patent entitled, &#8220;Methods for treating a fatty liver disease&#8221; (U.S. Patent No. 12,377,104) that covers the FDA-approved use of Rezdiffra with claims directed to Rezdiffra&#8217;s commercial weight-threshold dosing regimen as prescribed in the FDA-approved label was listed in the FDA&#8217;s Approved Drug Products with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Therapeutic Equivalence Evaluations, commonly known as the Orange Book, in August 2025. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Launched Rezdiffra in Germany following European Commission approval</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.4pt">Following European Commission (EC) conditional marketing authorization in August, Madrigal launched Rezdiffra in Germany in September. The EC conditional marketing authorization was based on positive results from the Madrigal&#8217;s pivotal Phase 3 MAESTRO-NASH trial demonstrating that Rezdiffra reduced fibrosis, resolved MASH and improved key noninvasive tests. Rezdiffra is the first and only approved therapy in the European Union (EU) for MASH. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Madrigal to have strong presence at upcoming AASLD Liver Meeting </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:11.4pt">Madrigal will have a significant presence at the upcoming American Association for the Study of Liver Disease (AASLD) Liver Meeting taking place Nov. 7-11 in Washington D.C.&#59; 15 abstracts have been accepted, including two oral presentations and two posters of distinction. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Third-Quarter </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> Financial Results</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Total Revenues&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Third-quarter 2025 net revenues were $287.3 million, compared to $62.2 million in the comparable prior year period. The increase is due to increased demand for Rezdiffra.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Operating Expenses&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Third-quarter 2025 operating expenses were $401.2 million, compared to $178.5 million in the comparable prior year period.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:11.4pt">Cost of Sales&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Third-quarter 2025 cost of sales was $</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">18.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> million, compared to $2.2 million in the comparable prior year period.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:11.4pt">R&#38;D Expense&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Third</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">-quarter </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> R&#38;D expense was </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$174.0 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, compared to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$68.7 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in the comparable prior year period. The increase was primarily due to the upfront expense for CSPC, partially offset by a reduction in expenses related to clinical trials.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:11.4pt">SG&#38;A Expense&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Third-quarter 2025 SG&#38;A expense was $209.1 million compared to $107.6 million in the comparable prior year period. The increase was primarily due to increases in commercial activities for Rezdiffra including corresponding increases in headcount to support commercialization efforts.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Interest Income&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Third-quarter 2025 interest income was $10.3 million compared to $13.0 million in the comparable prior year period. The decrease was primarily due to lower interest rates in 2025.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Interest Expense&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Third-quarter 2025 interest expense was $7.5 million compared to $3.7 million in the comparable prior year period. The increase was primarily due to a higher average outstanding principal balance after entering into the Financing Agreement. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.03pt">Cash, Cash Equivalents, Restricted Cash and Marketable Securities&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of Sept. 30, 2025, Madrigal had cash, cash equivalents, restricted cash, and marketable securities of $1.1 billion, compared to $931.3 million as of Dec. 31, 2024. The increase was primarily due to the Company entering into a senior secured credit facility managed by Blue Owl Capital that consisted of a $350 million initial term loan funded at closing, a portion of which was used to repay all outstanding obligations under Madrigal&#8217;s then-outstanding loan facility, offset by funding of operations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Conference Call and Webcast</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">At 8 a.m. EST today, Nov. 4, Madrigal will host a webcast to review its financial and operating results and provide a general business update. To access the webcast, please visit the investor </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">relations section of the Madrigal website or </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">click here</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> to register. An archived webcast will be available on the Madrigal website following the event. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About MASH</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is a serious liver disease that can progress to cirrhosis, liver failure, liver cancer, need for liver transplantation, and premature mortality. MASH is the leading cause of liver transplantation in women and the second leading cause of all liver transplantation in the U.S. It is the fastest-growing indication for liver transplantation in Europe. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Once patients progress to MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), the risk of adverse liver outcomes increases dramatically&#58; these patients have a 10 to 17 times higher risk of liver-related mortality as compared to patients without fibrosis. Madrigal is focused on reaching approximately 315,000 patients with moderate to advanced fibrosis who are under the care of liver specialists in the U.S. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Patients with MASH who progress to cirrhosis face a 42 times higher risk of liver-related mortality, underscoring the need to treat MASH before complications of cirrhosis develop. An estimated 245,000 patients with compensated MASH cirrhosis (consistent with F4c fibrosis) are currently under the care of liver specialists in the U.S.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As disease awareness improves and disease prevalence increases, the number of diagnosed patients with F2 to F4c MASH is expected to grow. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Madrigal</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Madrigal Pharmaceuticals, Inc. (Nasdaq&#58; MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal&#8217;s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-&#946; agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.madrigalpharma.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Forward Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This press release includes &#8220;forward-looking statements&#8221; made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended, including statements related to commercial coverage for Rezdiffra in 2026, the expected benefit of Madrigal&#8217;s newly issued patent, expected growth of Rezdiffra sales, Madrigal&#8217;s clinical development plans and timelines, Madrigal&#8217;s leadership position in the MASH sector and the potential benefit of Rezdiffra in patients with compensated MASH cirrhosis. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to&#58; the assumptions underlying the forward-looking statements&#59; risks related to obtaining and maintaining regulatory approvals, including, but not limited to, potential regulatory delays or rejections&#59; our history of operating losses and the possibility that we may never achieve or maintain profitability&#59; risks associated with meeting the objectives of Madrigal&#8217;s clinical trials, including, but not limited to Madrigal&#8217;s ability to achieve enrollment objectives concerning patient numbers (including an adequate safety database), outcomes objectives and&#47;or timing objectives for Madrigal&#8217;s trials&#59; any delays or failures in enrollment, and the occurrence of adverse safety events&#59; risks related to the effects of Rezdiffra&#8217;s (resmetirom&#8217;s) mechanism of action or of any other product candidate&#59; market demand for and acceptance of Rezdiffra&#59; our ability to service </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">indebtedness and otherwise comply with debt covenants&#59; outcomes or trends from competitors&#59; future topline data timing or results&#59; our ability to prevent and&#47;or mitigate cyber-attacks&#59; the timing and outcomes of clinical trials of Rezdiffra (resmetirom) and of any other product candidate&#59; the uncertainties inherent in clinical testing&#59; uncertainties concerning analyses or assessments outside of a controlled clinical trial&#59; and changes in laws and regulations applicable to our business and our ability to comply with such laws and regulations. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Madrigal undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of unanticipated events. Please refer to Madrigal&#8217;s submissions filed with the U.S. Securities and Exchange Commission(&#8220;SEC&#8221;), for more detailed information regarding these risks and uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. Madrigal specifically discusses these risks and uncertainties in greater detail in the sections appearing in Part 1A of its Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 26, 2025, and as updated from time to time by Madrigal&#8217;s other filings with the SEC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Madrigal may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Madrigal&#8217;s website in addition to following its press releases, filings with the SEC, public conference calls, and webcasts.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Madrigal Pharmaceuticals, Rezdiffra&#8482; and associated logos are trademarks of Madrigal Pharmaceuticals, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Investor Contact </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Tina Ventura, </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">IR&#64;madrigalpharma.com</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Media Contact</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Christopher Frates, </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">media&#64;madrigalpharma.com</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(tables follow)</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"></div></div><div style="text-align:center"><img alt="image1a.jpg" src="image1a.jpg" style="height:413px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image2a.jpg" src="image2a.jpg" style="height:368px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1a.jpg
<TEXT>
begin 644 image1a.jpg
MB5!.1PT*&@H    -24A$4@   \\   *&" 8   !TJZG3     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  %Q$  !<1 <HF\S\  /^E241!
M5'A>[)V)7MNX%H=+ J6=)RHA0'L?I24+M&_20A+H>\RT0 +/,=.R)*\QTY;M
MW'.TV)(L+T#8RO_[_7QO8TM'LFR8?!Q9?@8          ( *$
M /+X _(,           4 WD&          !*@#P#           E0)X!
M     ( 2(,\          $ )D&<          * $R#,          % "Y!D
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M+RQPWW5?<N59^B3EO?,IEF<Y)-.U[13P^'/2!5Q7GE6]FCD?R#,  #Q!(,\
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M=29X'$RK5G4CN/(L4F_.*5>>57]T>W;!,'4^.W+_7/*^+G7[/;[7G;;=[@,
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MF9J=E6H (LBT[69'34.'. ,  +@%(,\   #NG_&H0XN+#7^ZMJRX[;Y""P
M  #@_H \ P          )4"> 0        " $B#/          ! "9!G
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MBA ?]FP,V5?PJBK>5E=7J29_#+"?-S;4']>.^]VT'U_E>?;T; $ X)$">08
M    N!TBT[8!   \5B#/      "W ^09  !^(R#/      "W ^09  !^(R#/
M      "W0;HZMWX>& (-  "/&L@S          !0 N09           H ?(,
M          "4 'D&          !*@#P#           E0)X!         ( 2
M(,\          $ )D&<          * $R#,          % "Y!D
M "@!\@P          )0 >08 /%[&PPXM-OIT<JD_#SN+-/.L0>V]2S*[KLUP
M,*#Q91*89F:>D?RZ?-;>([O[L3/LU-+S:O1X''^3$[LB(_=:7Y51AVJU&3V&
MK5VZ^(W'<-2M4\W>+PN;='SQP,]UU*5Z<FUVZ.RA]_<1,MK:HI.+BY+?MQ/:
M6EZBSNX1G3_1WS$ @-\&R#, X#$RIO[B#,TTVK1GS9F9FCR++"^*E+NQN3WY
M$OX;R;.0"/13E6>17[[6-Q'!$8^ADLK?7)Z%1* ?@SPS27\AS]-GM$9SS1X=
MGI7),S,9T=;2+-4;&]7* P# PP3R# !X?&B197&^#5$9#VAQ9B8CD[^K/(\'
MBT]7GOE:-R4SR><.>:[&>-#4F7;(\]-FLD7+LW6:6;B*#(]H;6Z6:JM?Z?0<
MUP( \"B!/ , 'AEF"G6C=Y)^81OWM?"*W/*FCGE3K7NTUVYH^6VTJ>=DJUW4
M-'!;QXW%Q5-Y]F.% C\>2 S;EP:U3'W=;[._Q0(^;/N?31B_OK3A2NV8!I)=
MMWULM/SVN8U:$E/Z:<6XI<Y9EW1BR/X>GXOZ=]I.<1^J,1XY,:2?IGT1S:3_
MSYSV^7.C=\SRJ>L+7@PYSN?D]B-L8S<Y1SD'ECP;M]6B=L-</RG'C:BZ=DJO
MV1:"]EWLF*@8LBVDPIW*<X]V><S5-5C0[3B]->-NVO2.CZA3XW%1L1>H=WQ!
M)]Q>4]HS[4A_1?15&:E[[,:.P>UUFT%[CN1X4YK]?F]R^UZ_.4YRC*]7D3S+
MN-NX"SSN+9DA(F,3M#_F]OWS<=L<4;>>CL?FT3F/ARG/[1X%XC6VQU1YB2=E
M+M2Q5)XW:8?/L6[.8X>/IU$FM&7/T?3'/\[]85&L9?K#?31MR?DLV3XOK-+.
M$=?WNQD@;2ZE4_ZESOEYVN9HC68YGCV?G5V^_B;^PN8AG9^PB"[960!^W<G6
M6MH7[N_JQA&=R[623+&-N;I#IWL=_[.,JU=F@\?,7$]N8X//6\),N$P:7V\+
M&X?JCQ-^V[P%<CW96N;SFJ'5KZ<$?P8 /$(@SP" QX29KLU2FA%@%NB.^?)K
MQ3H17I.EKI(]SLO$>K%.3J*Q;%TKW/YGEA#5=ZYC9%G%4%_L30R3];;3SL=#
M_IQ,'S?U143Y<Z:N(7V.F<OQE]GD,Y>[</K0VN,OM.-AVB=[ODD?]!=>OP_5
MD/.6+_4BP^J\51]T?U@#63;-&-L^LB@.'?$5K/QJH1Y2IVG[+3'#XVD;J9#R
MOJ;Y$L_GI@34"G7.YUQ,AKJ]JX5H/#)C8NHD\LSGLWLL]T:8B39],>*>/2Y%
M=!LS(L^[QSS>M@Z+;4^+K9;[V+F&N.U=T# 1R%TM48;T&68NQP*8+:?CR+[6
M+HO3>)1\SL\\2QTK=2R67"81ZN#SPN:1/A_5KNY#$I''0TL8RZH=#Y'%1B#/
MIISJ'^\>C[:HV>S3,<<2W'/<.3I6YUA7YV@ST2RQ*JX6YF%W-CANF&RE_=GQ
M^[/#U\>>S_G%F*68]]=8:',SLM+F+-<5Z35MUKA-%M@SY]PF6TLT*^/&]_#J
MSAD+,_=A5OK LLIEC\Y/N \<A_LK\BK73-5A.8U]/I.^+9OS,[(\6IM+VK;9
MX&3?,^[?Z3D-(V6L!'MR;++1+2/&$[X62WPMCMQQN%;&&@  '@R09P# 8X(E
M2@ER;,JV/69D5?8$@AL3WI!2><Z-I=NW8J]V&1%5DGAY8L2?ZY3(L\W4^O"7
M=56?X[-<#]NF;J:?(E8ZIGSW]SZ?V R]EE8A<[Z%?:B"9%%-/TUVU,JT$G85
M4LY%2T"#VTFSXA8W1NP+=O:X%>&6$5S5A@BDM&$SRGQN(J@R(T!G=Z\FSS.2
M(<WTE7L3R'!V&K?IRXR(,<N2/>YDKY,VN+]^!MQFI75&6D53_9YQSC4D;,\(
MI-L>DV9EM2R'GW6?I.U4;%7;,H85Y%G+L>SB.%8\CW:ID_P[C2GR:058P75L
M!E-)::PIP9;+9*\UZ3EI&1YEY-C(,X_5YLXY[77,<1%]5^83>3;]23IJL])R
M/B8SR\(JYR/"FQ3S,/+LMBERRFT>.FTF\FSW2Q^4/'.]0VG+QN&Z2KR'M&;Z
MLJ&.JR!<AV55B? Q#:XBSP5EBN1Y9F&5OO)8Q.]-,W5;]3%O?   X,$">08
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M7 G.E6>GC"?/1WO4'9S0.?_N6%[B:R%_[-"!:&YVT9=D/@<L& 8 >,1 G@$
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M+U%GUY_"#0  CQ#(,P  @-^/=,$QO4&@[P89=_<Y8P@T  " WPC(,P
M    4 +D&0          * 'R#           E !Y!@          2H \ P
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M!]0Q,FPE.2\[;??K<AR[*[&XC^?V_'5[T@<EQJ8]U2='GJ7-9HWKNOL   "
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MG5\X4\(]81^S0!NQEK+RZJLP<\SM66%>:&WZ[=DB)AN-5U4!  !XHD"> 0
M/#UT]C<[=1OD8:9L*TG'B $  'B20)X!   \14R65M[)? *!+L1FI1N8K@T
M .!) WD&  #P=!F/.K2XV*<32&$.\D>&)K7W@BGN    P-,#\@P
M )0 >08          $J / ,          "5 G@$         @!(@SP
M    0 F09P          H 3(,P          4 +D&0          * 'R#
M        E !Y!@          2H \ P          )4"> 0        " $B#/
M          ! "9!G          "@!,@S          !0 N09           H
M ?(,          "4 'D&          !*@#P#           E0)X!
M ( 2(,\          $ )D&<          * $R#,          % "Y!D
M     "@!\@P          )0 >08          $J / ,          "5 G@$
M        @!(@SP          0 F09P          H 3(,P          4 +D
M&0          * 'R#           E !Y!@          2H \ P
M)4"> 0        " $B#/          ! "9!G          "@!,@S
M  !0 N09    >*B,!TVJS<R0_*<Z;UOH'=/%I:DPZE*]9LJW=ND\.7!_R#DD
M?5+; FT>75"V9R/JUFLTDY3C;6&3CLZG>PZCK2TZN3#M\WC-UNUX[=#9#<=K
MU)WE<W7Z']D6-@^O?5U&:TY\'IO#\]@XEC-:FW/B;-#AV?7B@,?&A+97GM.L
M<X^^^O2-3I.?L>#XNR_TD^\-87]]A>;J#7KWY91_3M2NJ3+9?DW/9VM)OYX]
M>T6?OOVB[(__/JW/\_V;E./MU2?Z]NM\JO?P_O8VG9R;F/OOZ<7SNF[KW5_T
MX_1F [#__@4]KSO]CVRO/OY#O\ZN=T9>_%<?Z9^?9]<:F_WW+[TX?U\SSF\&
MY!D   !XJ"AY;N_1\25_91EUJ&8DM+7+LG,YYETU6NP[\LR,NG46;OZR\T#D
M63$>4+>Y2#/V#P&QOK'(=CMIF=;NN7=>4T%DN=EC(4]E40FO&J^;R[-BLD5+
M]H\ JT[,R8BVENJTV+N^/ N)0-] GH5$H"'/3X_)-JT\GZ6:W*.\O?ORTQ/B
MR?8ZK>T=>3\/MRW/"N[7^HK\L<U(M"/O"?OKM-Y=I#K_C,7Z/A5$EI=[](\C
MY(F03D&>%9//]'I^3E\#-^9DGSZO/*>EC>O+LY#T]P;R+"B!GM5Q(,\*R#,
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MOO:6:+FS05\/W=]5DA%?X;;3:Y*^ZLHPX3BO8W'D#Y79<WF"0)X!
M ( 2(,\          $ )D&<          * $R#,          % "Y!D
M     "@!\@P          )0 >08          $J / ,          "5 G@$
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MY!D          "@!\@P          )0 >08          $J / ,
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M&!LV;-BP8<.&[18WR#,          % "Y!D          "@!\@P
M )0 >08          $J / ,          "5 G@$         @!(@SP
M    0 F09P          H 3(,P          4 +D&0          *"&4YS'U
M&\](=L6V1G]LR@$          $^&G,SSL,VRW"#7E8=M"#0         @"=)
M=7GFG=26#'2C3]!G          !/B"O(\[A/C1QY'O<;*BNMMS9K=IJI5EM2
MQP@X;VX&.U9?8Z:1MWF/;9\W^>C&4L=ECVTSZ&-^?$:=JSG&<89]IZX]9N(#
M         'B25)5G*ZIA-EH+:RK"1G:-O&J9#615)-B1T?SZCAPW&M1P8R9R
M[,BU08FR(\]%_>.CU';*<F&O+@          P!3)LQ%7LT63KRH;',_DJO(F
M6^S6'??;J8"7U5<?7=F5*JX<E\CS-?KG99X!         (!JF6>3 78-TQ*1
M;+O9;*\OOQS+,]6*]?/DN$R>J\8/]@$           X5IVT;"<WXL^Q/1#8'
MIZZ(K1>C0OT;RW-9_Q0FCI+H(%,-         ."I4WW!,)VA#9YY5M.>L\]!
M^UC![5.?-Z]HA?K%\EQRO#3^D(:N*4>F<0,         >/)4EV<VRR0[Z\JE
MEFH_6QO-,.=(:5G]2O+LR;+NHXU9'%^FI+OGJ<\QUD\          $^64)[=
MZ<MF<TW2D]-4.K6@IEOVV6&)FS\=.J^^MY_[H<39?HX),^\;JC)^6_G]D\RS
MLZHW;YXX&^GWQ@          P%,C)_,,            "^09           H
M ?(,          "4 'D&          !*@#P#           E0)X!
M ( 2(,\          $ )D&<          * $R#,          % "Y!D
M     "@!\@P          )0 >08          $J / ,          "5 G@$
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MVK;9 VX!EMSMT?D4__AQ5SC3MLT>< NP1'\>G>G5N!\FD&>09=@N?FX9  #
MT^8ZK[ "3X<KO<(*/"FJOKX*/$T./@2ON'IX0)Z!2[7%W@   #Q5LL\J Y B
MSTG+,\20(Q!2_APU>,K(*ZGF"Y]_?B! G@$         @!(@SP
M0 F09P          H 3(,P          4 +D&0          * 'R#
M    E !Y!@          2H \ P          )4"> 0        " $B#/
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MR'/X.2:]#A7.1\']:#>DSVY?*LIS2?RR\]&8/P)P[&3<JO8]5A<
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MQ77M_1 &!        (#?FQ)YKH21YT3 'A]#EMF,#K*(MZ=^3H]_K
M  #@"0)YEFQJM.^09P          &LBSGO8</O/,Y]2.3Z>^&9!G
M 'B$W%2>_>=C'^NSL-YSPVJ[V@)BU?@]Q@H         GB#3R#P#
M  "_-9!G          "@!,@S          !0 N09           H ?(,
M      "4 'D&          !*@#P#           E0)X!         ( 2(,\
M         $ )D&<          * $R+/'L$TR''IKT]#LOC'C/C4X9GMJ 0$
M        W"&W*,^>B/+6Z--8[9ZBE'+$?EO'O3'27]-'*[N-_A0B.^, >08
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M6,XO(QG85,8SQXV49NOYE+7AQH]GS8OZ$>QOZZGB:9S\_ENQMYO[1X/"\P8
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MH[,<4;YC(,\     N!FC;I/Z)Y@J"^)<Z156X,F1>1T5  [7>875+0)Y!@
M ,!UD==8%;T?&CQM1K0V-TOMBBMJ@Z=&?%5L #3RRJEY:B?/+C\((,\
M     $ )D&<          * $R#,          % "Y!D          "@!\@P
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MGC+QU;7O&<@S>"CXSTE[S\L#        P/T">08          $J / ,
M     "5 G@$         @!(@SP          0 F09P          H 3(,P
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MU((\3X?)9_H\.J,SUS-YWYL7<]1(,L ']/[E<VK_]1__O.HBPL'[E_2\:;/
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M+2>2[J^H'2X&YHFY>965'[=H*O:]R_/C8,ARDI$+%I*V:WC\.?/XMD.E&
M ,!3@"5Z,+RD2WPK!3%8HK=&P8)U %A8HK='Y_CC!XC#$OUY=$9GE=SVUGF"
M\CQL.QENAT!\A^V";&G%&    ,!3(/,:+  <KOP**_"DV%]_38.C@M=1@2=-
M^DYFL^-^>7KRK*?CAF(\=A98TE-HO>FW >4Q    @*= ?,5N #2R8O<LM7.F
M9H.GCGY]5;M@]6WPE-&OKVH7K+Y]#SS-:=O>\ZQJ*\@RYS"-&
M'@5/4YX!   \7FJU=*$0;-BP8<.&#1NV.]H@SP          0 F09P
M    H 3(,P          4 +D&0          * 'R#           E !Y!@
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M"WEX\IQ(GI+9!B6^S)^O+,\BCHV*\BS\#J)YU7,&  #PVZ/$=X8EHQ4(ZGA
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M[JQ,3XO?8[P         OSV09P   (^+6BU=  8;-FS8L&'#ANV.-L@S
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MRVX39)ROC$R73M_M?!?(:ZGFJ9W[&JI;HCSC;($\3Y_@&6T\" P
MCQW(,P          4 +D&0          * 'R#           E !Y!@
M    2H \ P          )4"> 0        " $B#/          ! "9!G
M      "@!,@S          !0 N09           H ?)\)<9]:O!PM8?F,P
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MPTNZA,& &"S+6Z.+[!]0 !!8A+='YR53\\&3A27Z\^B,SJH+[FT">08   #
MS1AUF]0_0?8/Q!FM+=/@./\Y:/"TV5]_38,C/(L,XA2^:NKN@3P#    X+K$
M5\X&0!-?71L 37SE;  T!_3AY3RUK_+JJML'\@P          )0 >08
M     $J / ,          "5 G@$         @!(@SP          0 F09P
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M%[<-Z6=)'T**X^OCZ;G+<5^<I=\-Z;<J8.H[$IL?OWP<51MN_YWSTQ^+^PX
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M_8P_UWPM#NC#RWEJ5WB7\U0ISSA;(,]W@_\LLKOH%P        " !P_D&0
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MN2^R8ZCV%IY[[AA&R+_NC!,[V7)BI>? ,1H2,RO/\7,1]/E(VVF9="RN<CX
M # ]8M.U\XB+;3%2IT-[=LIV%*<,R_52?9%Z09:Y,/N,Z=L W -YT[7SB(MM
M,5*G2[O.E&R?X#@+^.OG2[013-,6R7^1EWW&]&UP=>Y/GI4PN)DV*VU*'%C
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M0IZ9XK@GRFOVJ2#/A3$LW9-F?0$M[KNF(,\J?4R,G7.%OM@Z_/'T[U^Q/P
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MK=D%         ' *(,\          $ !R#,          %  \@P
M !2 / ,           4@SP          0 '(,P          4 #R#
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M:2,.'#APX,"! \?%')!G          "@ .09           H 'D&
M   *0)X!         ( "D&<          *  Y!D          "@ >08
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M&5&..%L@SP          0 '(,P          4 #R#           %( \ P
M        !2#/          !  <@S          !0 /(,           4@#P#
M           %(,\          $ !R#,          %  \@P          !2
M/ ,           4@SP          0 '(,P          4 #R#
M%( \ P          !2#/          !  <@S          !0 /(,
M   4@#P#           %(,\          $ !R#,          %  \@P
M     !2 / ,           4@SP          0 '(,P          4 #R#
M        %( \ P          !2#/          !  <@S          !0 /(,
M           4@#P#           %(,\          $ !R#,          %
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M==P_7#R@S8.,M$AZ%N>U71.]EDARIU\)M!;G+I=AO]CR_67Q[6U%!'JPVT*
MC3AW-UFV]ZK(\]$KG1^"='I$C)>VTN)<"?&3O#RK="R]GZSTCC=H?J[G"+1(
M[C(-#]S/(KT)@1Z\:Q&!-F5T7[)L[U61YR.3_]M4$>S;@T2<E[=BXJREV@IG
M0YZ/=^CAPARMV?/[3VEQOI\1:!'8AS3\:$78B/?C-RQE-D>8QHHT"_0_$8$>
MO&T1@3;BW'W!LKU'3TWD^:AU_MN-1)Q7MD)Q]B4W)L]*;D5BK?R^?T[W%I<R
M BUEKM+P@[W^GI[?X_OVZ$_ZXA4>U!W(LZ $>OU-+@(]@3PS6L1NN 2IOD\H
MFVWS3"&1*GI\FHC_-/V9D&(;(<^W&L@S.%_&-.C,4'^/OW#_<J=MLW1MC_@<
M'KQ3(X+;&]+GB!R-UY=H>-@VPB?I663[OO2ZY]2_>R*Z]?6X*&NI'E@)3Z*C
MW/UW(E?NM&V6IE=C^IG/#$J(X"YMU<(;<OR*5I8'M-;M4&<M)\]CVIB?H_Y;
M?]JWBECW1&RY?"[KU?@GWS-S49#RYV>IVX@4:RD>O./RLGZS3QLL<?VW+%<_
MW6G;]OF '"41X5W>H@_?,Q'<4)(-(MWS?5=\X^=JCNGX^)?_/4+J7^'Z67+4
M::YK9WSBWV\^M\KU=QN18BW%@[=?*>^_^_3L[@+U_Y)T[K1MSK\SIA/\<27-
M^V=TC^]/*OK+EDJ_WYVG)PUYUN+;_],___[Y/5I<2D63(\^'"/?#S7AZ6W=$
MGJ6LU_^[2^MO8M<4D\FS/A](D#EGCX8@N=?YXFCH2%9"JJRDZR/2#I=L_68:
MNIPT=3732!%U_FZW7:0VFR<EB][Y$?5-?M4^.6/+-"+JCT.=SC_?;.MD_6DW
M1JDZ4VWT2(T'$^;ONC<[]^SDKC708RUEU_6E_SBD#W_,JC\0V'ICG7'PR_+K
MRO:9L74=2KOM-#*N3W[X1WT[G8W+/+3I^=P$Z05I@S?%U;THST2/\XGP\KWK
MF3+[>\U?5Q4\+C-5W7NTY]R/2IZ#LJK21H,Z;WB-4?F[6W1HZW!$_&C8<_+V
M:0^B="L9#YJ19W!6I*=K>U'GM3918".RH?"ZT6?U[QEGJK;D&=">$EZ?MM.W
M1<AGE9#7D>=22T$;1%!ST[5%B-=I]_MGVN9TLSEY%@F>6Z+-<)JVC3X'D>4:
M%EXKW8''M)V^O;^Q8 2]CCSGT@.!Y3$S7;LB*L\Z:MP/H]'%Z+-/NW76MJZF
M)+>=OKW_["XM]/S(,YZ/$CK"&YNN79&29W5^F5Z&4>9B]-E'9%O664<%."O/
M<CD[?7L2>;:RYTJ%/F<]HA(,_9'AZ^YG*==^MA+BY!?\,HS8)>4O5[]MKYSK
M5M.*PS;&\^1DLY GT2]%0R(=<34HL3)E'QT9V0O:6\N6R3]U?]J/4:K.6!L;
M).2YD<^.G4K(;0NO59]SUT+J/LH?$G0_FL]5NH\VK7SF_-RV4G_]\?/KRO?9
MJ4L=G$=^:CG-#/\\=OE:7YV0="*WPPG3:Z&6-LQP&RI=5NDYO[K.XV77*=MG
M@C.)A*L\4D #SM/3Z?1'EF$GK99?79:<TY_M=;TNV@IS)<KJ&K>;)5ZUS8S]
MH6V[*4>D7R6U::N\X+8A JW6M"J)QD-P=B2$EU%18N</7Q-/V;8H8>Y54[7U
MU&W[A[_FFN@*)U_IR_9XG>5-VOI )!IR=#:(',]27Z*[D0$=;ZS0]F>17BW9
M97F6"'(@XB5Y5I'M85QX9?.PK'C7*(&6J9P/3)3;G <I$@(<$I/G1#1:RW.O
ML48Y1NL-RB3R_'!('V/"*YN'27W!E.X82J!G^?FX+Q(->2[SGI[=DXA]9I.P
MK#S/4_>/0+PGD.>L. L%>9:Z?E-U?8W5E9-G^8]6<*@O^ Y*BFK)5F+@BEI$
MFK*1YZ \A6J+4Z9+J7XF%$%/7B+UQ<KP:),G[)>E<=[(DI/0:U_X6>4/VF;N
ME2IBFOXPY3'*U,F$;6X0&X_8.4:WE_LP:EZOGIU(WGSDN3G.7AEM^U@81X4J
MR[\'NBS.6^JSR6/O1QT+%J&5?/5/L.2Q EQ'GBV9]-*&X)J@KDL;C'F&LJPB
MO,YG#RY3(LINQ-B]'[XL!V6IO'6].I+L1Y!CYW0^'E/WG(E@AY%K<)N0*=P2
M"67AXF_+> [. !5=[M'6YX)0F(AQ5G:5/'-9H6 '\LP)U91L+>8BY(DOJUS>
M<DS&DXQIG05-GH]W$*33DXH6,Q+U7=_[8:2DA3S;-+)^V2E/3=ON/*&W_ T\
MYDG[E:";$RYF2O=:)"H=1T_A[MSA^O@;=:LLMQ4EP'SO/\3_<%*1E.=(WA;R
M+-%BV8"L\A)OS7.3_:>KM'V0*$_$>E':5IJZ;=%3N&?O/*:_OG['\Y$C%3UV
M2<FSB5K/=_Q-PM2T[;E'].<7OI_Z5 -_DS$^&FN>#25YYNO_2U^?)/)L!(23
MAU_^!?6%7S76%XSZO!O9,X0R827#?)R$;/U.@Y6H\!=WU9)8?:4VM,D3]LO2
M.#^A/*MZ;#_]0XWM-/UARF/4K$\.>S_#-C>(C8<J-WS&&%.?I,T].]GGJH$>
M9S^=CDC7XU:7YQZM^VC)C7>+/@NVKK;R[/Y;DTG/=6E)-A<LZCSG8?'4'UEX
M97JT^B3Y,_+,J/35F-EHL$;)<SC5.E*62J?*B,ASF#Z8ZNT>W2V_?G";,&N>
M]_K489%;VV5!PL-P.I38=FFS),]"*K)L:27/$NE>XC3R[UJBHV5.(\\R;7MW
M0+.S_'RH==#F$I@<B0KS_6SLB,W2NK%]Z$SC;R//@A7HX/=Z*AJ\OT$;HV"-
MJ\LT\BS3MM\-:)X%[8E:!VTN 9]*="]6GFOL3MW-W;0KN+RGHQ_IZ/0T\BS3
MMM\.:'%AEAZK==#F$O"1]<Y\C[-1XJ0\"_[&7M61V4';QVP8EMJE^^+D6=#"
MX<J!E1CYXJ^^]$?%H19O[WI4GF/UIBG5GQ/#:'M5&V)]T+3*<Y[R[%P+F:8_
M0FZ,2G4*89L;).5Y@C'B<\U^Y*ZYM)#GT_;1HOJ5>(9;]MG6=7[R[%]32!LD
MSY3RK.%Q[MFIEK4 E^392K/4K:[%(L]AW<'4<  TSH9AXP$+=!\1Z-,BPMLF
M\FR0J=R]8>I55?$IX+(S^FQ'1ZQ'SN9AEM@F8HIIY9GKD;75<[-]1*!/0R+R
MK*/%]K_-S>-)L"E8$E5^0G[EVOH>_<C9[;3R+,\$B_G"7!\1Z!0I 0Z)R;,1
MWW#*MXXJK[5>\ZSD-S;]6Y!K&WOTK7'!85IYYF?BETSY7N@C IU"R>FTD><(
ME>RV2&O)Y:FN788\JW2UM*@O_9[$C&CDBD(H1J7/%CX_#,\)Q?HE";?7*5"E
MX2_=JFLQF0G*;- F3Z8?X?EL^\+/*G_FCPO3](?)MJ%4)Q.VN4%L/,PYMUY%
MU=[<LU-XKAI$Y-GME_OO!,4^6E)MX?/#H;Z6[K/&UG4N\BSMXVO2!N_W&;=A
MAMM@W)D_3B+/S?OA3N/.RK.*(->RW%J>51U\SV#/@(5H>_O(/%^A/'=;2Q](
M$1?>.+*YV!(-,V.N1#BYV[:)-(>;CTED>BFR,9@3L4Y_@1W3JU>'9E?M4)Y-
MWE1C08'\FN>:MI%G%[W[=B]< RV(%(?KG/=?T:O#G_Z];+7F>=]Y/D)Y;K=>
M^G9RBC7/S.2[;<>0-JS05AAY%BD.USGO[]#.X8F?KM6:YWW:V3FD$Y4@E.=V
MZZ5O)Z=8\]Q 1Y&7PC70123?0]J<)O(\_9KG4":<*)_Y\J^^Y#OIE(1YHB:R
M[9:CRZC<(2(:N@R_[E$_+G_E^LTYIP*5A[^(ZRS!'P,876:S#34M\D3ZI4CU
MU[;'7-=EZ?+=]H[84&)]E#2ZS&GZ8]J0'"-S/5EGLXT-$N.ARW7/NY*;>W8*
MSU4#^^S6??#&W7YNV<<2NBQ_O.TSG.^SQM9U+O+,_Q8QUFVPUZ4-[N9;.LTD
M\MSW1);+Z\VH\N5,3I[5OV6L3%X=A6XASTPJ[<#4"VX+LLXY?%752*]]QN9A
M9T!FM^V ?-39$$[=5@(<ON=9IMQ;J=5"';[G66BWV[:1?^]557MZ[3,V#SLE
M6HK3NVU;)I-G^U[H!REQ9F&WRX2J(S*UN]UNVWJ=L_^JJCV]]AF;AV4XS6[;
MC#KO1*[5E.WV.VT+(MLK6Q]8?ISZ19SEWH7/1V2CKW:[;>MUSOZKJO;HJ:Q]
MQN9A&4ZQV[:#7<-\?V)Q%O^]1P\W$_D*\CSA;MM6,M)';.JKO=9G0=#_MN(@
M$:D@C94&3Q2=\XP5C-@UGWS]7CE<B)(2^YF_C.N>^&7H5SOYXM,DDR?9KQ;C
MP&T:J38Z$N=<MWG"\<G=DU)_VHU1H<Y(&VL2_39X]7G7,\].]EH,(ZC\?+AC
M'0Y)JH_^>5^P4X1EN>U+]SFX)L(H8RN1XBKM+R[;3HT.CC;I)8VIQ_WRX8JV
M$F=[C:57[7!M/TO^QF\2<S_L+MU\>%%GFS=:5I#/^1G>XHJ\M@2B+'CE\X'U
MSK<5+=#NLR"O3OH9/"]@2D1P&^]YUE+M[K;M3Y_6TJHV;PL%50FT><55Y+J_
MV_8=Y[55+EJJR^]Y%K@M:J.PNJUWUMX5A ^THO2>9T5,GG5D66W.I=X3;#_S
MO6%IC9:G(LG.9D#.\6#J]SP+6J ]X7KREK]4M]6X6XH(;^8]SRJ2+#M4VS%E
MV?32&K'6X_XX$&>[IMF<5W(]6Y?%Q^-0R"-I['%_ZO<\"UJ@9]TR'_]%7['@
M.4_F/<_OG]VCA3EG/+VUS':]<GC>Q:8Q&XBIG;CGZO+X>)28XOW^^6^T&-;M
M2?*T[WD&X$;1C.X" &XBSK1M<*;HJ'(Y^GQAB- /]OSIW46<:=OF##@]LL9Y
M::L4?;Y@1+37=UG6)Q$<9]JV.0/RB" O;Q6BSU<1F7;-S\=D NQ,VS9G0!Z1
MY)6MR:/&EXI,V=YX1_^FPN&09W [@#P# ,#I:#]]^[QI-UT;7!QMIV]?#.VF
M:X.SH>7T[2M$N^G:X&QH,7W["E&8KFV!/(/; .09  #. MD9>S *-F:Z2*:*
M.(.+P'^W\R4Q5<09G);CG8>TL??=GT9]%9DJX@Q.BZQ=?KKW'_]<FA-7D7+$
MV0)Y!C<=?VVTNS$:         +0$\@P          !2 / ,           4@
MSP          0 '(,P          4 #R#           %( \ P
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M/7GW@TY* S7>H'D>?WM_ZN,)O?O>'.?QQCS-]M_1]TC!ZEJG+N/!RT_T(]9
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M[59MZ-DVZC;HJ;HLRR+@+$K5N)F^C 8L.56_P)5 Y+,W]"+"#23-4B$-4T>
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M)L/97?M"[]-[>GYOD?K9:=E7 L@SN#B\=<SJR*T_!BY:H(.QF^3=5
M (#3 'D&           *0)X!         ( "D&<          *  Y!D
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M23X; 0[SJG2)^J-IA>0X..O&4V/(5&WBH]N-1)X;T[;;E&O2J&M=JH8$
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M*53YD6AQ1;H]#<PUMXV*H&V3BF:N_D:?"N-0'L.@;V<DSYRB7ALMAU<)
M     ( ,B0W#/)G5$5=QK9R@:4FL\ZFT;>292:755:7;$T.7Y5[7Z=THJTIC
MVV&%6QVZ#6X[1RRON?K]M&8CM,PXJ,^),>2K1G#K]+H\.>>T86)YEC:[?0
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!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image2a.jpg
<TEXT>
begin 644 image2a.jpg
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M&F$2     - :81(     T!IA$@    #0&F$2     - :81(     T!IA$@
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M @">.\(D /R-W#U\"]*)E[6ZS5YMH@'SRI<!  "H09@$     +1&F 0
MM$:8!     "T1I@$     +1&F 0     M$:8!     "T1I@$     +1&F 0
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M83(.PSIVE_'W,3K3<#GEQF/^_:7<^L$8'2SYX/S$8=(%V:Z<W! F ;Q,A$D
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M?Y-?5WJ<OZ!V?__R@4C/_YL[/YN9L_,/@H6VY>Y[#-M:C-M*^UPV,YG?%P5
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MH*AA<DO[?AJ-B_MN[34C-BN;:P< ?C?")     "@-<(D     * UPB0
MH#7")     "@-<(D     * UPB0     H#7")     "@-<(D     * UPB0
M    H#7")     "@-<(D     * UPB0     H#7")     "@-<(D     * U
MPB0     H#7")     "@-<(D     * UPB0     H#7")     "@-<(D
M * UPB0 X,$,SS9E8?/4_N42[;"_)R;D5>>#?(OWW=-P?U_Z6E=2F[8Q:6WH
MO\I>O>K(AV\_T\_^1,-]69R<D EWOKIM?):?M6,[E/W%1>F>?M-R?A<   ^
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M29L:)M^6]"F8@4Q"J/:'5X,  .Z+, D N!^;670!I7I6$<_#V=LI#9,L<04
M/ S") #@WFSIZL2$7[;J]^&9\4MHP_M% 0"X#\(D .!!]-W2T*Z<$BB?G^&9
MO/7W>*8/Z $ X'X(DP" !^->D[%Y:O]R\7OP^]F]IHO2/65&$@#PL B3
M (#6"),     @-8(DP    " U@B3     (#6"),     @-8(DP    " U@B3
M     (#6"),     @-8(DP    " U@B3     (#6"),     @-8(DP    "
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M) 9!+0F%?OFJS38FP3$H5ZBO8I\3MS6?:SNW1+9IVR8IJ_MO@SH  '@LA$D
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M-<(D     * UPB0     H#7")     "@-<(D     * UPB0     H#7")
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M6^::[//'GOF_TQ ZDB.M?T;[83.02:;+A;T?^H&KJULW,QGTRV^%6<\881(
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MKN&^>,:QC)9S2U:KRHW[//"H8?+CGBS-^GLARP)>Z,YA,A;.4J;]21 F 0
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MC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D     :(TP"0
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MS/)T,JNX^^6'Q/\-( Y\<[M?Y(??&8='MT]_*X6Z9LOK"KDZ9GP )4P"
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M20    ! :X1)     $!KA$D     0&N$20    ! :X1)     $!KA$D
M0&N$20    ! :X1)     $!KA$D     0&N$20    ! :X1)     $!KA$D
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MD]_D8$7[W]F5KW_Z+*4&R7]FN_+QBX9#-ZZK\MK&]<N/=%P'A[+3_R;7KL!
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M:"0C_><W7UM41_E,8EK_C$SEPZ2?L5S[E%T>^S"SDU&8M#:_W_2# *DA:OM
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MEH1=<Q8\#,?ZGX0^]ZD/D$%8RP1#MR=5]5E^?WFYJG.8",[!RDQ*-_G;A.,
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M-L(D     * UPB0     H#7")     "@-<(D     * UPB0     H#7")
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MA$D     0&N$20    ! :X1)     $!KA$D     0&N$20    ! :X1)
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MYU(V)F'_XBW^+,>=8U"N9%S=N?DRG:[U7__.3"?7?UY]+G7]'-<F  # ,_1
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MFAJ'J]\>)N]R+LW;SG A4LNY>QG]$W8+_P% ZX[OR[0M?P]GU>?W^E[&M0D
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M$28!     *T1)@$     K1$F 0    "M$28!     *T1)@$     K1$F 0
M  "M$28!     *T1)@$     K1$F 0    "M$28!     *T1)@$     K1$F
M 0    "M$28!     *T];I@<#J7?[4CG55?Z?A<     X.5K$"8U$/:ZTNF\
M$BL6;1H0NWW]I*C?C8/C4'K),83)ERK]/I^_E]17  #P4HUD<+@E2XN3TGE_
M+M>WO_S^HL'VK$Q/IM?0\WOUY?4 F9V>3,J'V]JG'W+S,R@W,U5?KK;,][0N
M_':CP8ZLS$[)I'T_<VOR[OQ:;FI^)K'1D1ZGWW%\W,?OUU+\6D=RM+,B,U/^
M=U57_V@@.ZNS,F6_6:OOJ]8WIA_U87+8DXXUVNE)/TR.P[X/BAW13)ERY;,7
M]/VNE>,B_T4J^3Z?K9?45P  \$*-Y'!E618G)F1"KY%KP^'HT%WH6SEW$:_;
M^G$0"$ODPV>ZK<FG'S=)4+!R,U/UY6K+?$_KPF^F0?*?V:Y\_!(%M]'1JKR>
MZ<B[+_I;J0MR@R/9Z7^3:W>0AL#7&@+GWLD7_6[3PRQ(;LOIA0^%5F[%PN*<
MUO\]5[]^]K]9Z7[\XNJT@/O:^O7OM=SZ$F6JPV00),MF(+5 $BA[KD#\-V'R
MSU#^?3Y/+ZFO  #@Q?-!L5,3)BW,+7T8,Q.9,9#M[7VYO+D-PH"R&<:WG^5'
M.BW9H%QUF==:YCO3DL^$!KA_9F7AW1?]WN)O2@/@ZFN9Z6@P_!$&PY"6.1K*
M39 &1T=O-(1NR,?_@MG)T9$<#6^RH5'WO7D](QUM\WOPP6#G?S*[&(91;>.-
M]F/]H_Q[71TG*\)D/BA62 )G5[JN?+A%%_9IF-0ZNYWH,RV?O^@?VE+:^%C[
M/#,3&MY[V8_:J@JYF;+U;=H,:[?C/]>M4]ONF+JJ%-J(9WGC,;8MKD_+^G*O
M;,JW[KP;C$GS,<V?6]BW>+/]%=PY!F5+QR<MT^EJ/^V89%J[[K-(];G4]75\
MO0   *V-"Y/!K.3\^IZ<7-Z.72XHHY&,?OTJA(?!]HKL7UY+TDR3<DWKPN_E
M9B6G9.WC?W(=Y/O&LY.!P<X_LOPA&Q#+13.0%F#3LM&^Q5S C +J>NWL9'F8
MC$-B78!P].+<E8M"9]DL9+2O(]V>113EZ^X$*778TU"C%_G1YW&=<3UA6+!E
MM4,MTBVT$\F5S;7I EHB:L?J<[3=Z-C\3&N3NBJXLEI?TH8_-@E]<1O!N6@9
M=_X:?JK/>_R8M!K3BG-K-JOLZT[:*A\?JZN;?.<69+/M5'UFZL\E4M;7<?4"
M  #<R9@P.3JT>]0F_+66;?.R?GQ]A_L4![*]LB^7U[D9QH(FY9K6A2=3$28K
M]Y<::?$56>X>R[D6'OO=NIG))=D+E[GZV<KUC_\6^O&_V45Y]W_Y);&I\C#I
M@HG^\*MF_Q)I*+%K]*H+^NP^?TQR46_A('N,A8>XSEA9W57&M^G+Y(-%21!J
M4E>YJ%P8FHW-!H;UC:N_[KRK/[OKF#9O.Q6%N_0\?1V9WTY4)CMDNL_MJ/O,
M_]]W.I=Q]0(  -Q1@V6N=I$_&IW)UO*23$Y8L%R7X^"^QR8LE"[W+L8NE6U2
MKFE=>$(:XE8UQ$VN?93_@A37>&8R/EZO>9L^N,>6LQ9F,%UHM/!:%B:GY/_9
M_HJIR=\?)N.V2K8PB#4+-I&Q;5JHR-4?RQ];6U=)WY,F?#!-_JXPKJ]UYUWY
MV9W'M'G;9=PRTGA);^:WX^NU]KNYASG5?J;N>RY6KJQ>  " NVH4)E.CP;;,
M3$^.?YIK1O2PG][%N&6I3<HUK0M/R]\?.?E*@USTX!M[2,[1RJSN6\O>_UAC
M-#B2E5D+E6..L1G(E9Z<9Q[2HQX\3,8S=&.#1'S!/FZ9:W5@B<+"^,#2)MB,
M;=.?7UF8C&:]TF-KZWK68;+\F-!]VLYP(5++NGL9_7+APG^(T+KC^S)MR]_W
M6/79O7X?=6T"  #<4<LP:5H_D,?:6.[)Q;AEJ4W*-:T+OX$]<35^=<><K+T[
ME@]+&B8WLK.58VGPJU\::P_469'>><F2U8IEKM$]DYT[+'.-0X7NK@U#<>CT
MP:'L@GY<8(G"PEU"5[6Q;>HG-C.9_IUJ%2;KQ&,SIMRX^NO.N_*S.X]I\[93
M?I8W:<S7436K[1_\8_TKU%WVV4/\/NK:!   :.L)PB1+7/]2+A0NM'KX3B1Z
M,FRW(DP.=M[(ULGWBJ#YT _@,;F@6.0?:.)G)4W9!?VXP)*T8_6$TT:Z/WUX
MRIBPD#.V3555G^UOLQ2TFB^GY]:)'W 3TX 4'UY9?TU CU5^=N<QS9Y;7=L)
M%_;2WT"^_Q'=9T]3]7\Y>IQ[.)$&O>K/]/^^S[G4U0L  '!7=PJ3V]*_:7K/
M)$M<_TK^?9'95X4TY&87<P_6\8I!TA[:LRW[^IN(RS[PJT$\=_%MP4 OTL,+
M\'A98^["/+R@[_?L0MX'"]V7EO.S@D'8B!^HDMW"NM-Z:H.-4U:VV&824G1?
M?&[%I\0VK*N*J\^.SV]I?=&YQ^>J =U>@>':U$W'/1KGLO.N'Y.[C6GVW(K?
M9PE_CG$ MS&,Q]7NH8S&-FHK>2*K[4G&NNXS__?8<RGKZ_AZ 0  [J0V3.J%
M^O:6['^^E-OH3?$R.-R2MZ<WP=-<K<R,3$]6/.6UZ;+4)N6:UH7?9Z2_AX-M
M69Y9D(V/^IO*O$?&@M]KF9V:D[6//Z) Z!Z\LR0;[X[E0G\\OWSP6]K+SBP:
M"Y*S;@EM[EIZ+@R.*EGJ&MV[V616TM2'29.\CS!HO!.\3B(4SB+9C),+*_%F
M%_$^K,1;$,CR[Q$LAIYXRX:(K'9M:KI(WD-H6_9!+2WKJC#L][)M%.[;2_O@
MWH7HVK578?A7A"1;61 L^RS5?$PKSBWS??I#2R1+2/VY1<'.?B/Q0=J>_5YL
M-C%N-QF'NL]2U>?B%?K:K%X  ( V;+GJ]*2_MG!;_BFM(SG<7I:IR>C5(//S
MZW)RH9]GKO%MMG!&IB;T^/D].<\%/9:X_BVBI:E3K^9D;FU/C@N_$Y,^I,<%
M0/VM_=+CCE;M(3W^-VA/<CV^D)O<P0,-A+,S)4%2M[G<DE9' ^7.JOXN75MK
M\O'K]=CWHXX/DP     >Q>#P4*YNF37$>(.C([FZR3V)]3<C3 (   "_P^A0
M#L]NY3:_S!7(&QW)T5FX5/IY($P"    3\KNHSR0_K=O\O,7<Y*HH[^5H^?[
M6R%, @    !:(TP"     %HC3 (  /SA9F9F2I_HR,;&QG;/C3 )     &B'
MF4D     0&N$20    ! :X1)     $!KA$D     0&N$20    ! :X1)
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M'8\+^I$/DX.=_\ELQ6_EX[\5YU6A,DQF V)YF'0*9>L-M;P%T+\I3#[$.0,
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MC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D     :(TP"0
M  !HC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D     :(TP
M"0    !HC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D
M:(TP"0    !HC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D
M    :(TP"0    !HC3 )     &B-, D     :(TP"0    !HC3 )     &B-
M, D     :(TP"0    !HC3 )     &B-, D     :(TP"0    !HC3 )
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M-MEWU^-"Q<]*9L)JI$\B#>NHTFP\?EN8S''O?6S15F$L'RA,9MJS$-XXM0,
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M6->"H07>FGZ$ 7;LE@2WH"WM3]16OHS)]LGZDGR?NKFBI6->\?UD1&4RS0$
M  #X;:IG)H%*56'R<?5Y\ X   #P;! F<0=/%";]+&;4A+99MOP5    P&]!
MF$1[P]Z3A,EX2:X]^,<]6=;O!P   /#[$2;13O@PH'A[K$"9M)5_2!    "
MWXTP"0    !HC3 )     &B-, D     :(TP"0    !HC3 )     &B-, D
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M)     "@-<(D     * UPB0     H#7")     "@-<(D     * UPB0
MH#7")     "@-<(D     * UPB0     H#7")     "@-<(D     * UPB0
M    H#7")     "@-<(D     * UPN2C&TJ_UY7.JZ[T_9Y8O]N15R7[Z\7U
M=:0W]+LJE-=___[<K=\     _B0E87(HO<XK#0O9K3,NN3P#_>XS##C]KA_#
MNX>W4+\;?R=W#)-WZ$]^7 F3  #@3S,ZV)+EJ4F9L.ND^74YOKF5G_ZS*H/M
M69GN'LN/F_*2[O/)^-KME<SOG<OU[2__:;G1X;8L3P?]N+ZIZ,=(!H=;LK0X
M)9WW7TOK'0VTKIDIF;2ZYM9D]^)&QC2/1FSL=6R7=.SWOLB/RD'-E;LI+S<Z
MVI&5^'MZ-2=S[X[E7']33;ZJP<X_,CN5_L;FWGV1[[EV&M4_V)'_S4XE]83;
M__OXK_Z^?+F<ZIE)#1T=W=WIOI#(,.R5SK8]!U$ ?+B^#7L6YL:'R2JM^O.,
MQQ4  .!!# YDJ_]-;G_JY?5H(%LSTS(YOU=_0:]!;59#WZOUBC Y.G07\"X4
M^FW]^(=4Y,[(X%"VM1\WOA_;KA^[<JY7\KEX((<KR[(X,>'JG]\M"9/6OYFN
M?/JJ8=2J.US1_G9D]^LU@?)>=.Q75V1I<M*%L[G=JC"9*Z<AKRQ,CHY6Y?7,
MAGS\<NV^)_O>=U[/RD)%^8S1D:R^GO$A,=K6/OXGU\%O;'3TIK+^,'0.=OZ7
M":7IMB8?_]7?C"^75QTF78AX&3.2Z6PJ8;*)YOUYWN,*  !P?R,Y.!C*3W>E
M'1D=+,O,U(8<_ZB:G=2@M[(D"Q;F*L*DS4HN?1@_$YG2\'$XE-N@O 7 F>D-
M^?2C8G;2!=9IZ13"I/9O=D86,OLM@,[*=&=7OA;"*5K3L5]];6-?-S.I7+D9
MZ52$0S>SV/TH_P4)L&Q?&2NW_*$X$QF*Z_HW4[\&Q\P^#9@[^W)Q?5.<K=PZ
MT7)54?(AP^2P+]V.A1P+'WI<1P-(?.APJ &FXV>X-*"X99):SLKX(K&ANY_/
MU]'M:>EQRI;EIO6&];GVP@HS_;+^6QG?YK@^Z_BX\KIO7#_+P]M0AZS\WL5H
M+*.Z,VUZ:9@,^J5_=WJ94I7U-^M/U;C6]%O5CK>3GIL;-SO7ES+[#0  _@J#
MK2@(NAG"$H/M%=F_/)%-FSDL"Y/!K.3\^IZ<7&HHK<D;5<8&TJHPZ68EIV3M
M4W8FE-G)!_1 83*:F9R4M8]?Y-K]2#38K2[+AW/][NJ^HV!6<F[MG1Q?1#/0
M>=',9*[^-U;_][3^T4A&OWX5_@/#8.>-[%\$Y4H\4)C40*!ENW%RT( 0!1$?
M>))0TI&N!IXHK$7UOPJ"1';&S<)<?%RV7)FR@&3UV3+=J+JHCVF97+^T[Q:2
MXL!4U^=.MRL]?Z[1,7;N[L]2I>'-'U?8KW^Y?B;]KAJG,,3:0W5\J(S+5=;?
MKC^%LC7UUH]WQ.KK)K\I_QW7#1X  ,"3&6F07):E[HE<W%8L<=6@MK)_J>'M
M3+9GR\.DFU&<FO#73+;-R_KQ=?T2UPSMQ[;OAQY4>2W?,DS:_M=NOP:$QGU!
MJ0<*D_9='ZV^EIE)#85S:[*QT963"[\DM48<0M/?V)P&QN^9):X1K?]-^_JC
MT+DO%]]SLY4Y#Q(F2P-!+@05 XP/;,EQ^;^5KZ-)UBC6;V$F&V3B$!;65SPN
M-;[/JL$X5;51OC\*86E]OLUXQM3VN/,H+G/-U]>NW?+]3??IW@;C'9U;]OO4
M?4V^8   @,<T.G /JXD??+-W43:;:$M%#^2;6R9J2TDK9B:=D8Q&9[*UO"23
M$Q8LU^6X:KEJR ?$N!^U#\VI"I.V7_LVL?8ITS=F)A_0@X5)HX%O1P.?W;.H
M@>_C>9.P9Z+?V/;*LDQ-6K#48__38_VGJ?;UVXSF:N]K[1):\P!A,A]^4F'H
M* :0BC 9A*9"'Y)9L72+#R_47U(VWL*^E@>CR/@^JP</DRFW!#1>.MP@3,;G
M7#DF7IO]3??I3MUG^XM;.C9^_&Q?MU>R!!8  .#W&@TT5$Y;J+3PE[UGTL+8
MUFD\PS@N3*;LJ:HSTY.-GN8:&PT.M1\6*M?O<,^DOS]RXI6L??JJ_=7/1@,Y
M7)Z1Z<DU^?2]0:A%O0<,DX.=5=DZ.9>+_K:LS-I35ZM"8;718$=>Z[%E3W.U
MY:J%^O^MJ]]F,U>E][5^B:NY?YBL*1>%GBAT% -(23#30&)UQ<ME"S-;K<-D
M+O"4* U&7J,^/T:8="%2/W/W'/HEPR\B3!;K+-(Q3.[SU*WTODH  (#?:+#E
MGM1J3U^]C:^X+;AMG<IU$AR;ATG3_H$\RI:K:C\*RU5CE6'2:*#<7I;I*9L5
MG9.UW1/YL*AA<N.3AHWQ_<48#Q0FW7+5I3WY\L,O)XWOA5P;_P">O+('\KA[
M)JW^>+FJUO_&UQ\^E"?#RJSVY.N8):[F[F&RW_-A)IJ9S 0LKW685.ZA-[;?
MA8WH7L8F"O7G@E65TF#D->KS@X=)/].;M.';;! F\_O;M5N^O^D^W:G[QH]W
MPC_@*/J>BWT!  #X?0:RI4&Q&X3)XGV0X38O>^?U2T?O%"9]8.W>*4SFN/LE
M%UCB^E >)$SZ^R4WLL$Q>5U(R]G)8ICT]TMJ_6%P3%X74C$[V72)J[ECF+2
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MA$D     0&N$20    ! :X1)     $!KA$D     0&N$20    ! :X1)
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M\6HH#6M5?;%AC/:'WZ^U&8;)J)[X./ON]7-W#KJY\:T^I\)O(MKM5819  "
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M     * UPB0  , ?;F9F)KL"B8V-C>UA-L(D     * =9B8!     *T1)@$
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M6B#<EM,+'T23@#HG[[[H=UG9G3L>%_0C'R8'._^3V8K?RL=_*\ZK0F68S%Y
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M69>]]UU9]/=7VE+7BW'AR86_17G?9)GK8%M6]B^C&3\-H&5A<G2X(C/3X7\
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M/XY>SN^%, G@^= @F3RA-=X>*U F;76X5Q(  . ."),     @-8(DP    "
BUI(P"0    ! <Z]>_7\9C'N0/N#%[0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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MCA%7<*2G+PF1?.KR?ROJ\FHCIH!5\ERZ0N9OB1(EU@7N@"+J' ^Z+[W<"9
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MG$JP9R +%Z/B+PW.L]RN)/)"Q-\?Y,=T..H]K^V(_[=%U[47SR>&Q(<9G?G
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M#"KCG>#ZW#*+DDA=_KUKOT0R!!V23^"XI<F22OJ=KB2$\\@_-B<$Z?^U%QF
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6\O\B9#GS"GV6N@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mdgl-20251104.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cbd92466-6b99-4701-9438-a726300e9607,g:ce9ea39c-4a4a-46a4-9263-4308ab4f25b2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdgl="http://www.madrigalpharma.com/20251104" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.madrigalpharma.com/20251104">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdgl-20251104_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdgl-20251104_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.madrigalpharma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>mdgl-20251104_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cbd92466-6b99-4701-9438-a726300e9607,g:ce9ea39c-4a4a-46a4-9263-4308ab4f25b2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_7ef9d1ca-81a9-40be-8956-73fa39283337_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_3e2764a7-a932-4317-92a3-4aae0212d409_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9a4e3085-1282-470a-adc0-633b030813ff_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_734f2259-2857-49e5-bf76-978153f1201e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_a7c7c5e4-d780-4dcc-962b-1d32f27b294a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_21edd7fe-4aca-45cd-aee6-d34173c79f07_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e982a9d3-e572-4172-acf4-15c8795b8ee5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b671d2fa-0fc6-4e81-88e5-7e1a04e39018_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_819687a6-e12a-4b64-b932-7b05c8258e67_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_defd0991-e904-4985-8458-c179839cd842_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_707c03f7-2c32-41b6-8631-3fec70aa61c6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fe536853-3b17-4a0b-8fdf-b7ec0ac6111f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_600572c5-2bde-47bb-b637-8f489cd5bd2d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_63f3f0f0-9be2-4f8a-8cb2-3f8d760e4c70_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_19493ffc-01e3-4770-9b20-ace2855b6fde_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_84c17aeb-6825-4b5f-b060-7515eec1cef1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_03b3959d-1070-45c5-b934-86282d0b59fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5fe6cd2c-252b-43a4-80c3-00cb76a5094c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f38b8409-2abd-4e7f-8ef6-f64e12406e93_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c75b7a2d-3b0b-4839-9f9f-65474cac4a2d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_54ea9cb1-f650-4b5f-a994-a654336edd1f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c59a14be-478b-425c-81e5-8d3da7275558_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e2a2d733-a798-40cb-ab3c-cd305fdde1b2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>mdgl-20251104_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cbd92466-6b99-4701-9438-a726300e9607,g:ce9ea39c-4a4a-46a4-9263-4308ab4f25b2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/Cover" xlink:type="simple" xlink:href="mdgl-20251104.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.madrigalpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f92bef99-4c21-4fa5-948b-23d9164e9504" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_DocumentType_f92bef99-4c21-4fa5-948b-23d9164e9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a5042f4a-c0de-433c-816a-641a089bb84f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_DocumentPeriodEndDate_a5042f4a-c0de-433c-816a-641a089bb84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9fba1117-badf-4e64-bbea-1bd8bb4747a6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityRegistrantName_9fba1117-badf-4e64-bbea-1bd8bb4747a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d9d4b149-5c66-4f94-8b4c-09247cda4910" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d9d4b149-5c66-4f94-8b4c-09247cda4910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_641fd398-e1bf-4603-972d-e6d52c4d06cc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityFileNumber_641fd398-e1bf-4603-972d-e6d52c4d06cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_20c22227-193a-44f2-a838-930de0e2c129" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityTaxIdentificationNumber_20c22227-193a-44f2-a838-930de0e2c129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_742c91c7-1a6e-4561-8f97-c909022e9669" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityAddressAddressLine1_742c91c7-1a6e-4561-8f97-c909022e9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6ec47187-bc43-47f0-8156-ac3b27657d55" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityAddressCityOrTown_6ec47187-bc43-47f0-8156-ac3b27657d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e0cce809-2070-4998-8307-acca5ddc29ee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityAddressStateOrProvince_e0cce809-2070-4998-8307-acca5ddc29ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_24082275-0b03-4842-ab1c-40b18254bf89" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityAddressPostalZipCode_24082275-0b03-4842-ab1c-40b18254bf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3c38b110-3e1c-4c56-b025-828d280a099a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_CityAreaCode_3c38b110-3e1c-4c56-b025-828d280a099a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0612457a-3cf8-4687-9062-d5df7de2ad74" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_LocalPhoneNumber_0612457a-3cf8-4687-9062-d5df7de2ad74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_be75bc06-29aa-4b7d-b9f5-dc81e3aaaa51" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_WrittenCommunications_be75bc06-29aa-4b7d-b9f5-dc81e3aaaa51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e34988e7-1598-4398-812d-43465a785a97" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_SolicitingMaterial_e34988e7-1598-4398-812d-43465a785a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b6933f53-483b-4493-a2e7-ebecbe51eba6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_PreCommencementTenderOffer_b6933f53-483b-4493-a2e7-ebecbe51eba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7ff4eba3-f0f5-438b-afac-2b2aeaa5c01a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7ff4eba3-f0f5-438b-afac-2b2aeaa5c01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e6d55a82-fa4f-45d2-b8b7-0d9b9dd83e4e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityEmergingGrowthCompany_e6d55a82-fa4f-45d2-b8b7-0d9b9dd83e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7d936568-8780-46e4-b8f5-181fa600d4c4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_Security12bTitle_7d936568-8780-46e4-b8f5-181fa600d4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_592357f2-ce73-44b1-930e-8918c28e8ac0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_TradingSymbol_592357f2-ce73-44b1-930e-8918c28e8ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4e161214-bd45-4771-808b-f728b6bf9d27" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_SecurityExchangeName_4e161214-bd45-4771-808b-f728b6bf9d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_084b3906-b3ae-4bb4-ae66-55498e490030" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityCentralIndexKey_084b3906-b3ae-4bb4-ae66-55498e490030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_695fb3b5-812e-4cd3-9aee-c88dc80627d0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_AmendmentFlag_695fb3b5-812e-4cd3-9aee-c88dc80627d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_12cce3e9-1969-4d79-8877-29bd1db990fb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ad704a12-6291-46cb-b861-23720d831015" xlink:to="loc_dei_EntityAddressAddressLine2_12cce3e9-1969-4d79-8877-29bd1db990fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  04,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MADRIGAL PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3508648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Four Tower Bridge200 Barr Harbor Drive,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">West Conshohocken,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">824-2827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 Par Value Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDGL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001157601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mdgl-20251104.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.madrigalpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="mdgl-20251104.htm">mdgl-20251104.htm</File>
    <File>mdgl-20251104.xsd</File>
    <File>mdgl-20251104_lab.xml</File>
    <File>mdgl-20251104_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mdgl-20251104.htm": {
   "nsprefix": "mdgl",
   "nsuri": "http://www.madrigalpharma.com/20251104",
   "dts": {
    "inline": {
     "local": [
      "mdgl-20251104.htm"
     ]
    },
    "schema": {
     "local": [
      "mdgl-20251104.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mdgl-20251104_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdgl-20251104_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.madrigalpharma.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mdgl-20251104.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mdgl-20251104.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.madrigalpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-25-048525-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-048525-xbrl.zip
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M".([B;%9/E[ZYB=:)*29%@K*RZ=<67BG?H3[!AWXQ4?N=)>:_\:Z9HZA:/F
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M(2ZJ\KAL1<+*Y*](74PEL>;O,'!5%,A%/88Y3QJPAT?3PI7YU<&]Z47"YW(
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M MM>J;ZX#O;O!:NK=0]4.XT- +4][LB8=IK;AK1[N2^B']/9YL-.!IF")&$
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MT=?],!1[&_?'L<W8<" ;47\.DFW&=D+9NOAP6.)I2(W@2B+;"$.X.E,C.*=
M6"X)B8S6KI^UMZC\3"RO[K/A6.(!6#JY/R"67<8/@B4^"I;XYV.)7;#$ [#<
MW,1[9=\Z52$7B,KR4_G8-D@<*A C$X)8$RT89F$8]KZ;HA[XR/ ]W>!=:KG?
MOEY9WP^7KR$WGOIY\;I#O9[XH!O3JT"CWX]>3[_M-O3&ZQ[?_5&BE1M1G1LP
MV(Z"C! @&(\!A4H"(8D"2A,8)EH;)'M?S5P/?&00JL.34LOQ+$G#^WX2?!VY
MD=#3C-MWGK1D[O>5)_5 XWWC24OZC2\\:7M]%PKUBMHN\OWTU>:9=/4ELJ>O
M_@]02P,$%     @ ?#AD6]!V;5#@!@  !#,  !4   !M9&=L+3(P,C4Q,3 T
M7W!R92YX;6S56UUOX[82?<^O\'5?RYBD*)$,-BG2=/<BN&DWV$W1HB\"/T:V
ML+)D4,HF^?=WI,3M>I.T@J7"VCSX0Q[I#,\<D3-#Y<T/]^MB]AE"G5?EZ9P=
MT_D,2E?YO%R>SG^]>4?4_(>SHZ,W_R'D]Q\_7,U^JMSM&LIF=A' -.!G=WFS
MFC4KF/U6A4_Y9S.[+DR356%-R%EWVD6U>0CY<M7,..7QUFS[:SAQUFLNDH0D
M5FLB)&5$BT@1(WD240HZH?+[Y8D##2;2C@@C#!&)$42C 1$15<:*C,>6=Q<M
M\O+32?MB30TS'%Y9=U]/YZNFV9PL%G=W=\?W-A3'55@N.*718FL]?S*_?V9_
M%W763&N]Z'[]T[3.7S+$R[+%[S]??70K6!N2EW5C2M<"U/E)W1V\JIQI.M;_
MT:_9JQ;M-[(U(^TAPCB)V/%][>=G1[/9(QVA*N #9+/V_=</ESN0:^,Q/*;8
MK$Q8FV-7K1>MV>*B0EF@P]T%FH<-G,[K?+TI8'ML%2 [G:_]LB!M9!FCHH7]
M[O'$Q5_HFP U2J8;[14>>#J_1=G7$[AOH/3P.,8M3E&Y':.B9;CZ\\S"6"BZ
MHZF'/.VN>F[K)AC7I,9+*@QREW#-4%[.$JL21G@D.?4J8I3%NP-O':_1\RX@
M-;CC9?5Y@1=>M&2T'SI6.D:>P3VRLY_?VSOP!FW33',+67O?.(YN9R;&FT=9
M=-MKE@C0,16#W/X2;=?K+Z-Z'MRL"AX"3B%;.!/<LPCOBO?)8K$Q 2]$W"HO
M_/;L+%3K,6+55",P]Q@6='<^PU%G$ +XJ\>HO#JX;F0-3JS068X1\6L(>>7?
MEOXGG'E3@P[R#.="1SW@-!@YHEAB2"*8H4I;JT0V2NAW8'MI@$]? _MS>6 Q
MO"V;O'GX ,N\9:)L?C%K2'5F#6-,$FM\1@0D@E@+AC#KE;5""FF205IX";67
M%*+I2F$PDY-0PB5F:V%3A8[XC\@_7%2W91,>+BH/J==>6"8TB1UF6"+3@B@K
M'*&8<DGGC=",CB",OW6BET[$U'4R'L^3D,V[O(!?;M<60HJ37.8CK0@PBY)/
M,(?4DGL"B8^Y$YXFSHV@D;\0>PDBGKH@]F1P$M&_,?>7'KG*L_RQ"'D:"*>.
MXY\D3$=89&%518S"6DQ'N"Y2X(YQ/8(47H'OI8MDZKH8@]M)B.3<>PQ!_?2&
MA1NP5 KN-',X")-@HA0C*RK3DCA-->4<B_5D#(&\ -U+''+JXAC*Z92$<8$?
MWX>;ZJY,$W!",H59DQ,1$3*CF#_'"3$NLEPFL?3QL.KY%>!>HE#?B"CVY'-*
MDNCRHO?A.E2?\])!"M0Y4%1C,"4E0N,2J2(J<1S.Q-X[K@'&T\57Z+W$H;\1
M<0QA=DH*N:[JQA1_Y)LN;>:"*EP28T(MYDQ""5P3+7-$4,L4CX7-U(C+R0YV
MOV86_4;DL3^M!Q9'.^F=!S"=WY&+E&6,D@A:;QW.>!:C2117GBMJJ-9F6!/V
M"[1^ IAP.W-OZ@X<\G;CH[A>5>6V?*()XR*6AD0N4T@ KGN:)ISXV&?2 T>"
MAC6QOT;L%_H)=S$'47C@\/\6\J:!\J):KV_+IQ*I3BW(V#J:$*X-5D=6>F)U
M%A/O%(/(X%_,!FG@1=A^0IAP#W,XF0=6P\>JR%W>Y.7R9TQP0FZ*%"*AE0*L
MAV+,:D3;5U&,>_PDDMA(%1LM!TGA.68_'4RX1SF0Q@.+X#I JV# Q+;;GVNW
M=L/[#/U(;:*C*(O;+":R1 @=$<-Q4&#!68@9V($[&Z]C]Q/%A/N4(]$Z+7%<
MUO4MA"_'(K-,H+\1R2C.<0+S(&(RXPBWW !.=8ZR85GC/WG03R@3;ER.2O$D
MJLVW:PA+G W_&ZJ[9H6#VYCR(6W[\;%1G&1&9$3$GB,_5A+JM=4>"0(Q1COB
M1?!^(IE\ W,XL8=..,#=8M+TP+B]R9L"4NEUE,0)KHY24>0#!/J.*F>*92:A
MU LWK/KX&K&?$B;<M1Q$X8'#?Q-,^VSCQX>UK8HTUCR*9<:) XEKH;"LW8X!
MHC13CBM0Q@W;'M^!ZQ?X"7<D]R=O(C?]VWNW,N42ND<]!#"LFAEJU0M<U*1D
M1%%<V3+)E4ULICT?6&>\@-KO^:D)MQT'4SF)_. "N0JFN,04Y_Y_\)!2)6RD
ML6*VD0&LF*T@!I*$Q#$642 T.C'&<S)?P?83PX1;D,/)/+ :SC'?]6W.^ZXP
MRS31<68C&[>%,CKN?$2T 2!.*>\43;CTPU2P ]<O^A/N0NY/WB3F@.=[\3QE
MW#F(0!.F$TV$EYHH)27AVGKFK=8TL__*\PV\GQHFW(H<A]31E/%F\8Q(].;3
MV='3#^U+^T\39T?_!U!+ 0(4 Q0    ( 'PX9%L9]C]S\18  !6#   5
M          "  0    !A,W$R-7!R97-S<F5L96%S92YH=&U02P$"% ,4
M" !\.&1;K#)/LH(/  "];0  $0              @ $D%P  ;61G;"TR,#(U
M,3$P-"YH=&U02P$"% ,4    " !\.&1;3:=?FV0"   +!P  $0
M    @ '5)@  ;61G;"TR,#(U,3$P-"YX<V102P$"% ,4    " !\.&1;?&L:
MGD(*   46   %0              @ %H*0  ;61G;"TR,#(U,3$P-%]L86(N
M>&UL4$L! A0#%     @ ?#AD6]!V;5#@!@  !#,  !4              ( !
MW3,  &UD9VPM,C R-3$Q,#1?<')E+GAM;%!+!08     !0 % $<!  #P.@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>mdgl-20251104_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mdgl-20251104.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001157601</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001157601</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-11-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">MADRIGAL PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33277</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">04-3508648</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">Four Tower Bridge200 Barr Harbor Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">West Conshohocken,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">19428</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">267</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">824-2827</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.0001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">MDGL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
